THERAPLEX F TAB 0.12MG DIN 00753742
Health Canada record
| Active ingredient(s) | IODINE (POTASSIUM IODIDE) 0.09 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | A12CX OTHER MINERAL PRODUCTS |
| Original market date | 31-Dec-1989 |
| Current status date | 24-Jul-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Therapeutic Products Inc — licence 3-002321, not currently licensed, last inspection rating C (2017-02-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IODINE (POTASSIUM IODIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00310670 | IODE FORTE 8% | DISPAR, DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | IODINE (POTASSIUM IODIDE) 8 % | Cancelled Post Market |
| 02231903 | IODINE | THORNE RESEARCH INC. | Capsule | IODINE (POTASSIUM IODIDE) 0.22 MG | Cancelled Post Market |
| 00540129 | IODINE CTR SRT 300MG | BIOENERGY INC. | Tablet (Extended-Release) | IODINE (POTASSIUM IODIDE) 300 MCG | Cancelled Post Market |